A review published in 2007 confirmed the data on a favorable safety profile and good tolerability of meropenem in various categories of patients with severe infectious diseases.
Patients hospitalized for community pneumonia of risk classes III-IV according to the PORT scale and treated with ceftaroline have shown high clinical and microbiological efficacy of the treatment.
The specific name of the causative agent of Pneumocystis pneumonia - Pneumocystis carinii has changed to Pneumocystis jiroveci.
Candida toxins do not affect the development of antibiotic-associated diarrhea and there is insufficient evidence that excessive growth of Candida alone can cause antibiotic-associated diarrhea in adults.
In studies of the effectiveness of using a 3-day course of azithromycin at a dose of 10 mg / kg / day in children with acute tosillopharyngitis caused by group A streptococci, contradictory microbiological results have been obtained.
Cotrimoxazole is often used to treat acute otitis media (OSA). Israeli scientists conducted a study on the bacteriological and clinical efficacy of cotrimoxazole in the treatment of ACC.